Venus Concept Inc. (VERO)

Market Cap	24.67M
Revenue (ttm)	107.85M
Net Income (ttm)	-38.12M
Shares Out	69.33M
EPS (ttm)	-0.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250,104
Open	0.360
Previous Close	0.351
Day's Range	0.350 - 0.374
52-Week Range	0.150 - 1.690
Beta	0.90
Analysts	Buy
Price Target	2.21 (+520.96%)
Earnings Date	Mar 27, 2023

About VERO

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional ...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Domenic Serafino
• Employees: 407
• Stock Exchange: NASDAQ
• Ticker Symbol: VERO

Financial Performance

In 2021, Venus Concept's revenue was $105.62 million, an increase of 35.39% compared to the previous year's $78.01 million. Losses were -$23.01 million, -74.09% less than in 2020.

Analyst Forecast

According to 9 analysts, the average rating for VERO stock is "Buy." The 12-month stock price forecast is $2.21, which is an increase of 520.96% from the latest price.

Price Target

$2.21

(520.96% upside)

Analyst Consensus: Buy